As preclinical data, Scribner et al. reported that IMGC936 exhibits cytotoxicity in ADAM9-positive human tumor cell lines, along with bystander killing and potent antitumor activity in xenografts derived from tumors and human tumor cell lines [115]. The gene discussed is ADAM9; the disease is neoplasm.